Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years

The European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, becoming the first vaccine to be approved for these age groups in Europe.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthEuropean Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years

The European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, becoming the first vaccine to be approved for these age groups in Europe.

View Premium plansBrowse free archive reports